Werewolf Therapeutics, Inc.HOWLNASDAQ

Revenue (LTM)

$2M

-90.5% YoY

Net Income (LTM)

$-71M

-88.7% YoY

Free Cash Flow

$-56M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	16	20↑21.6%	2↓90.5%
Gross Profit	-1	0	14	18↑30.9%	0↓99.6%
Operating Income	-22	-50↓123.6%	-56↓11.9%	-41↑27.7%	-74↓81.7%
Net Income	-15	-50↓234.6%	-54↓7.7%	-37↑30.6%	-71↓88.7%
EBITDA	-14	-50↓249.7%	-51↓2.9%	-32↑36.7%	-64↓97.3%
EPS Diluted	-0.98	-10.94↓1016.3%	-1.86↑83.0%	-1.05↑43.5%	-1.63↓55.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	93	158↑70.2%	129↓17.9%	134↑3.9%	111↓17.4%
Total Current Assets	93	161↑73.4%	140↓13.0%	138↓1.3%	113↓18.3%
Total Assets	96	179↑85.9%	160↓10.6%	175↑9.1%	127↓27.4%
Total Current Liabilities	5	12↑124.7%	24↑102.0%	19↓19.2%	15↓21.7%
Total Liabilities	7	26↑268.6%	38↑43.2%	63↑67.4%	54↓15.6%
Total Equity	89	153↑71.2%	122↓19.9%	111↓9.0%	73↓34.1%
Total Debt	3	16↑516.3%	15↓6.2%	52↑253.6%	37↓28.6%
Net Debt	-90	-142↓57.6%	-115↑19.2%	-82↑28.1%	-74↑10.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-19	-43↓130.2%	-41↑5.3%	-33↑19.7%	-56↓72.3%
Capital Expenditure	-1	-0↑11.1%	-4↓625.1%	-1↑78.7%	-0↑67.0%
Free Cash Flow	-19	-43↓126.1%	-44↓1.9%	-33↑24.5%	-56↓69.1%
Stock-Based Comp	1	4↑547.9%	7↑80.7%	8↑8.2%	9↑10.2%
Net Change in Cash	75	66↓11.5%	-28↓142.8%	25↑188.5%	-43↓273.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance